Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Linezolid for Infants and Toddlers With Disseminated Tuberculosis: First Steps
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 63, Issue suppl 3, Pages S80-S87
Publisher
Oxford University Press (OUP)
Online
2016-10-14
DOI
10.1093/cid/ciw482
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimal Clinical Doses of Faropenem, Linezolid, and Moxifloxacin in Children With Disseminated Tuberculosis: Goldilocks
- (2016) Shashikant Srivastava et al. CLINICAL INFECTIOUS DISEASES
- Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests
- (2016) Soumya Swaminathan et al. CLINICAL INFECTIOUS DISEASES
- A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies
- (2016) Shashikant Srivastava et al. EBioMedicine
- Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments
- (2015) Jotam G. Pasipanodya et al. CLINICAL INFECTIOUS DISEASES
- Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes
- (2015) Tawanda Gumbo et al. CLINICAL INFECTIOUS DISEASES
- Correlations Between the Hollow Fiber Model of Tuberculosis and Therapeutic Events in Tuberculosis Patients: Learn and Confirm
- (2015) Tawanda Gumbo et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and Academia
- (2015) Tawanda Gumbo et al. JOURNAL OF INFECTIOUS DISEASES
- Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy
- (2015) Ashley N. Brown et al. mBio
- Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2015) Taeksun Song et al. EBioMedicine
- Thioridazine Pharmacokinetic-Pharmacodynamic Parameters “Wobble” during Treatment of Tuberculosis: a Theoretical Basis for Shorter-Duration Curative Monotherapy with Congeners
- (2013) Sandirai Musuka et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Serum Drug Concentrations Predictive of Pulmonary Tuberculosis Outcomes
- (2013) J. G. Pasipanodya et al. JOURNAL OF INFECTIOUS DISEASES
- Linezolid for the treatment of drug-resistant tuberculosis in children: A review and recommendations
- (2013) Anthony J. Garcia-Prats et al. TUBERCULOSIS
- Comparative Pharmacodynamics of the New Oxazolidinone Tedizolid Phosphate and Linezolid in a Neutropenic Murine Staphylococcus aureus Pneumonia Model
- (2012) Alexander J. Lepak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis
- (2012) Myungsun Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of linezolid in infants and children: a retrospective multicentre study of the Italian Society for Paediatric Infectious Diseases
- (2011) S. Garazzino et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- An Oracle: Antituberculosis Pharmacokinetics-Pharmacodynamics, Clinical Correlation, and Clinical Trial Simulations To Predict the Future
- (2010) Jotam Pasipanodya et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Moxifloxacin Pharmacokinetics/Pharmacodynamics and Optimal Dose and Susceptibility Breakpoint Identification for Treatment of Disseminated Mycobacterium avium Infection
- (2010) D. Deshpande et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Ethambutol Optimal Clinical Dose and Susceptibility Breakpoint Identification by Use of a Novel Pharmacokinetic-Pharmacodynamic Model of Disseminated Intracellular Mycobacterium avium
- (2010) D. Deshpande et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical efficacy and tolerability of linezolid in pediatric patients: A systematic review
- (2010) Elena Chiappini et al. CLINICAL THERAPEUTICS
- Promising Antituberculosis Activity of the Oxazolidinone PNU-100480 Relative to That of Linezolid in a Murine Model
- (2008) K. N. Williams et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started